24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
23andMe
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:12
Intel nears $8.5 billion U.S. funding as Qualcomm and Arm circle for acquisition
16:43
Immunai signs $18M collaboration with AstraZeneca to make cancer drug trials more efficient
16:21
Ofer Ben-Noon’s billion-dollar journey to Palo Alto Networks: Mentored by Zohar Zisapel
14:25
Zoomin’s journey from bootstrapped startup to Salesforce’s AI arsenal
More stories
Buzz
Most popular
Daily
Weekly
1
Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference
2
Salesforce acquiring Zoomin for $450 million
3
Ofer Ben-Noon’s billion-dollar journey to Palo Alto Networks: Mentored by Zohar Zisapel
4
Intel nears $8.5 billion U.S. funding as Qualcomm and Arm circle for acquisition
5
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
More news
23andMe
1 stories about 23andMe
23andMe’s promise of genetic testing has been shattered
06.06.24
|
Viki Auslender
Three years have passed since the IPO of genetic testing company 23andMe and it has faced a nosedive in profits due to public mistrust, a one-time use product, ethical concerns about user data, and security breaches
Please ensure Javascript is enabled for purposes of
website accessibility